| ALCL | Anaplastic large cell lymphoma |
| AUC | Area under the curve |
| BL | Burkitt lymphoma |
| B-LBL | B-cell lymphoblastic lymphoma |
| cHL | Classical Hodgkin lymphoma |
| CI | Confidence interval |
| CRP | C-reactive protein |
| CV | Cross validation |
| DLBCL | Diffuse large B-cell lymphoma |
| ELISA | Enzyme-linked immunosorbent assay |
| ESR | Erythrocyte sedimentation rate |
| LD | Lactate dehydrogenase |
| NHL | Non-Hodgkin lymphoma |
| NLPHL | Nodular lymphocyte-predominant Hodgkin lymphoma |
| OR | Odds ratio |
| PMBCL | Primary mediastinal large B-cell lymphoma |
| PTGC | Progressive transformation of germinal centers |
| PTLD | Post-transplant lymphoproliferative disorders |
| ROC | Receiver operating characteristic |
| TARC | Thymus and activation regulated chemokine |
| T-LBL | T-cell lymphoblastic lymphoma |